CenterBook Partners LP Invests $8.32 Million in Agilon Health, Inc. (NYSE:AGL)

CenterBook Partners LP purchased a new position in shares of Agilon Health, Inc. (NYSE:AGL - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,920,265 shares of the company's stock, valued at approximately $8,315,000. CenterBook Partners LP owned about 0.46% of Agilon Health at the end of the most recent reporting period.

Several other large investors have also modified their holdings of AGL. Vanguard Group Inc. raised its stake in shares of Agilon Health by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company's stock worth $59,114,000 after buying an additional 272,787 shares during the last quarter. Capital International Investors raised its stake in shares of Agilon Health by 72.0% during the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after buying an additional 9,346,295 shares during the last quarter. Millennium Management LLC raised its stake in shares of Agilon Health by 187.8% during the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock worth $13,704,000 after buying an additional 4,706,357 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Agilon Health by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company's stock worth $13,168,000 after buying an additional 35,207 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Agilon Health by 8.8% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 4,939,576 shares of the company's stock worth $21,388,000 after buying an additional 398,027 shares during the last quarter.

Agilon Health Stock Performance

Shares of NYSE:AGL opened at $2.24 on Tuesday. Agilon Health, Inc. has a 1 year low of $1.50 and a 1 year high of $7.73. The stock has a market capitalization of $925.18 million, a P/E ratio of -3.84 and a beta of 0.16. The stock has a 50-day simple moving average of $2.40 and a 200-day simple moving average of $3.25.

Agilon Health (NYSE:AGL - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.01) by $0.04. Agilon Health had a negative return on equity of 45.47% and a negative net margin of 4.04%. The business had revenue of $1.53 billion during the quarter, compared to analysts' expectations of $1.50 billion. During the same quarter in the previous year, the business earned ($0.02) EPS. The company's revenue for the quarter was down 4.5% on a year-over-year basis. Analysts predict that Agilon Health, Inc. will post -0.59 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on AGL shares. Citigroup raised Agilon Health from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $3.25 to $5.00 in a research note on Friday, April 25th. Needham & Company LLC reiterated a "hold" rating on shares of Agilon Health in a research report on Friday, March 21st. JMP Securities reiterated a "market perform" rating on shares of Agilon Health in a research report on Monday, April 28th. Robert W. Baird dropped their price objective on Agilon Health from $6.00 to $5.00 and set a "neutral" rating for the company in a research report on Tuesday, April 15th. Finally, Wells Fargo & Company dropped their price objective on Agilon Health from $6.00 to $5.00 and set an "overweight" rating for the company in a research report on Tuesday, May 13th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $4.71.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.